A detailed history of Black Rock Inc. transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,121,154 shares of SGHT stock, worth $7.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,121,154
Previous 1,432,553 48.07%
Holding current value
$7.57 Million
Previous $7.56 Million 87.07%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.13 - $7.15 $3.53 Million - $4.92 Million
688,601 Added 48.07%
2,121,154 $14.1 Million
Q1 2024

May 10, 2024

SELL
$4.02 - $5.89 $155,879 - $228,390
-38,776 Reduced 2.64%
1,432,553 $7.56 Million
Q4 2023

Feb 13, 2024

SELL
$1.29 - $5.86 $227,230 - $1.03 Million
-176,148 Reduced 10.69%
1,471,329 $7.59 Million
Q3 2023

Nov 13, 2023

BUY
$2.88 - $8.8 $10,702 - $32,700
3,716 Added 0.23%
1,647,477 $5.55 Million
Q2 2023

Aug 11, 2023

SELL
$7.46 - $10.67 $388,971 - $556,344
-52,141 Reduced 3.07%
1,643,761 $13.6 Million
Q1 2023

May 12, 2023

BUY
$8.44 - $13.35 $1.7 Million - $2.69 Million
201,294 Added 13.47%
1,695,902 $14.8 Million
Q4 2022

Feb 13, 2023

BUY
$5.58 - $13.94 $17,683 - $44,175
3,169 Added 0.21%
1,494,608 $18.2 Million
Q3 2022

Nov 14, 2022

BUY
$6.1 - $11.41 $1.12 Million - $2.09 Million
183,016 Added 13.99%
1,491,439 $9.47 Million
Q2 2022

Aug 12, 2022

BUY
$6.61 - $11.99 $956,804 - $1.74 Million
144,751 Added 12.44%
1,308,423 $11.8 Million
Q1 2022

May 12, 2022

BUY
$11.56 - $17.9 $5.86 Million - $9.08 Million
507,029 Added 77.22%
1,163,672 $13.5 Million
Q4 2021

Feb 10, 2022

BUY
$17.36 - $27.36 $1.04 Million - $1.64 Million
59,887 Added 10.04%
656,643 $11.5 Million
Q3 2021

Nov 09, 2021

BUY
$22.34 - $39.1 $13.3 Million - $23.3 Million
596,756 New
596,756 $13.5 Million

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $171M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.